Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $20.1900 (3.59%) ($19.5000 - $20.4800) on Fri. Oct. 11, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.67% (three month average) | RSI | 17 | Latest Price | $20.1900(3.59%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.6% a day on average for past five trading days. | Weekly Trend | EDIT declines -7.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(63%) ARKG(59%) IWO(58%) XBI(58%) ARKK(55%) | Factors Impacting EDIT price | EDIT will decline at least -1.335% in a week (0% probabilities). VIXM(-32%) VXX(-17%) UUP(-6%) TLT(-3%) SHY(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.335% (StdDev 2.67%) | Hourly BBV | 0 () | Intraday Trend | 2.9% | | | |
|
1 - 5 Day Possible Target | $4.45(-77.96%) | Resistance Level | $22.63 | 5 Day Moving Average | $20.2(-0.05%) | 10 Day Moving Average | $21.03(-3.99%) | 20 Day Moving Average | $22.63(-10.78%) | To recent high | -24.7% | To recent low | 3.6% | Market Cap | $1.254b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |